Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl; Anja Schoeberl; Ralph M Wirtz; Samuel Murray; Eckhart G Hahn; Gunther H Wiest

doi:10.1097/JTO.0b013e3181654423

Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl^* (First author), Anja Schoeberl, Ralph M Wirtz, Samuel Murray, Eckhart G Hahn, Gunther H Wiest

^*Corresponding author for this work

Research output: Contribution to journal › Case report › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	314-316
Journal	JOURNAL OF THORACIC ONCOLOGY
Volume	3
Issue number	3
DOIs	https://doi.org/10.1097/JTO.0b013e3181654423
Publication status	Published - 2008

Keywords

MUTATIONS
GENE

Access to Document

10.1097/JTO.0b013e3181654423

Cite this

@article{6b84770e6167455dba4c5e61ae6eccf9,

title = "Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).",

keywords = "MUTATIONS, GENE",

author = "Brueckl, {Wolfgang M} and Anja Schoeberl and Wirtz, {Ralph M} and Samuel Murray and Hahn, {Eckhart G} and Wiest, {Gunther H}",

year = "2008",

doi = "10.1097/JTO.0b013e3181654423",

language = "English",

volume = "3",

pages = "314--316",

journal = "JOURNAL OF THORACIC ONCOLOGY",

issn = "1556-0864",

number = "3",

}

Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC). / Brueckl, Wolfgang M (First author); Schoeberl, Anja; Wirtz, Ralph M et al.
In: JOURNAL OF THORACIC ONCOLOGY, Vol. 3, No. 3, 2008, p. 314-316.

Research output: Contribution to journal › Case report › peer-review

TY - JOUR

T1 - Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

AU - Brueckl, Wolfgang M

AU - Schoeberl, Anja

AU - Wirtz, Ralph M

AU - Murray, Samuel

AU - Hahn, Eckhart G

AU - Wiest, Gunther H

PY - 2008

Y1 - 2008

KW - MUTATIONS

KW - GENE

U2 - 10.1097/JTO.0b013e3181654423

DO - 10.1097/JTO.0b013e3181654423

M3 - Case report

C2 - 18317076

SN - 1556-0864

VL - 3

SP - 314

EP - 316

JO - JOURNAL OF THORACIC ONCOLOGY

JF - JOURNAL OF THORACIC ONCOLOGY

IS - 3

ER -